James A Johnson is of Athira Pharma, Inc.. Currently has a direct ownership of 5,000 shares of ATHA, which is worth approximately $2,150. The most recent transaction as insider was on Mar 29, 2023, when has been sold 5,000 shares (Common Stock) at a price of $2.4 per share, resulting in proceeds of $12,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5K
0% 3M change
0% 12M change
Total Value Held $2,150

JAMES A JOHNSON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 29 2023
BUY
Open market or private purchase
$12,000 $2.4 p/Share
5,000 Added 50.0%
5,000 Common Stock
JAJ

James A Johnson

Bothell, WA

Track Institutional and Insider Activities on ATHA

Follow Athira Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATHA shares.

Notify only if

Insider Trading

Get notified when an Athira Pharma, Inc. insider buys or sells ATHA shares.

Notify only if

News

Receive news related to Athira Pharma, Inc.

Track Activities on ATHA